EcoDrugPlus

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSLCRG00005006106
Gene Symbol: LOC104940359
3 Cross references
189 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSLCRG00005003023
Gene Symbol: DGAT1A
3 Cross references
190 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSLCRG00005007579
Gene Symbol: DHODH
3 Cross references
172 Possible Orthologues:

Dihydropyrimidine Dehydrogenase B

Ensembl ID : ENSLCRG00005013062
Gene Symbol: DPYDB
3 Cross references
211 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSLCRG00005014439
Gene Symbol: DDR2
3 Cross references
190 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSLCRG00005009764
Gene Symbol: DDR2
3 Cross references
204 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSLCRG00005021427
Gene Symbol: DRD1
3 Cross references
188 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSLCRG00005011635
Gene Symbol: DRD1B
3 Cross references
198 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSLCRG00005012386
Gene Symbol: DRD2A
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSLCRG00005022236
Gene Symbol: DRD3
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSLCRG00005019376
Gene Symbol: DRD4B
3 Cross references
181 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSLCRG00005016693
Gene Symbol: DRD5
3 Cross references
144 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).